My guess is that the PR today was from a new source writing up on BRILACIDIN news that was for the most part news already KNOWN and previously published elsewhere. Good to have more exposure regardless
(2)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.